Company Filing History:
1 out of 19 
1 out of 18 Years Active: 2003-2006
Title: Mark Osborne: Innovator in Genetic Research
Introduction
Mark Osborne, based in Needham, MA, is a distinguished inventor in the field of genetic research. With a total of two patents to his name, he has made significant contributions that have the potential to impact diagnostics and therapeutic approaches within medicine.
Latest Patents
Osborne's latest patents include groundbreaking work on isolated nucleic acids that pertain to novel genes located on human chromosome 11q13.3. This invention encompasses not only the genes themselves but also the proteins encoded by them. It details expression vectors and host cells that incorporate these genes or their fragments, alongside antibodies targeting these proteins.
Another notable patent addresses nucleic acid and amino acid sequences derived from Klebsiella pneumoniae. This invention provides isolated polypeptide and nucleic acid sequences useful for diagnosing and treating various pathological conditions. It also covers antibodies against these polypeptides and methodologies for their production. The invention's applications extend to the detection, prevention, and treatment of bacterial infections, demonstrating its potential utility in clinical settings.
Career Highlights
Throughout his career, Mark Osborne has refined his expertise by working with reputable organizations such as Genome Therapeutics Corporation and Oscient Pharmaceuticals Corporation. His work within these companies has enabled him to leverage his innovative ideas and contribute to the advancement of genetic research.
Collaborations
In addition to his innovative endeavors, Osborne has collaborated with notable professionals, including Gary L. Breton and John P. Carulli. These partnerships have fostered a collaborative environment that promotes the exchange of ideas and enhances the development of cutting-edge technologies in genetic research.
Conclusion
Mark Osborne’s contributions to the field of genetics underscore his commitment to innovation and the advancement of medical science. With two patents and significant collaborations, his work continues to pave the way for new diagnostic and therapeutic methodologies that hold promise for the future of healthcare.